CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 9 years ago You may also like 59:44 Webinar: Development of Imaging Biomarkers for Becker Muscular Dystrophy (March 2022) 3 years ago Research & Clinical Trial Webinars,Webinars 1:04:50 NIH Hosts Working Group to Better Understand Immune Response in Gene Therapy Trials 3 years ago Research & Clinical Trial Webinars,Webinars 48:51 Webinar: FibroGen DMD Pamrevlumab Phase 3 Clinical Studies Highlight (February 2022) 3 years ago Research & Clinical Trial Webinars,Webinars 59:31 Connect with the Experts: Pulmonary Care (October 2021) 3 years ago Care Webinars,Webinars 1:09:52 Webinar: SRP-9001 Micro-Dystrophin Gene Therapy Clinical Update (October 2021) 3 years ago Research & Clinical Trial Webinars,Webinars 1:29:24 Connect with the Experts: Cardiac Care (September 2021) 3 years ago Care Webinars,Webinars 1:05:58 Webinar: SRP-9001 Micro-Dystrophin Gene Therapy Clinical Update (June 2, 2021) 3 years ago Research & Clinical Trial Webinars,Webinars 1:00:42 Webinar: Connect with the Experts – Navigating the College Campus with Duchenne (May 2021) 3 years ago Care Webinars,Webinars «1…56789…25»Page 7 of 25
by: Parent Project Muscular Dystrophy
